Dr. Mark Weaver recently assumed the role of Chief Executive Officer for Cambridge Technologies. Dr. Weaver was previously CEO of Newsham Choice Genetics, then a private consultant and partner in WW Research. Dr. Randy Simonson, who also serves as a regent for the University of Minnesota, will continue to be an integral team member with Cambridge Technologies as its Chief Strategy Officer. Updated contact information for Dr. Weaver is available at aasv.org/directory/. Are you on the move? If so, let us know at aasv@aasv.org.